elapsed_time: 18s
was_input_captured: False
original_text: |
    Localized adenocarcinoma of the prostate with the following features
    * cT1-T2c
    * Prostate specific antigen (PSA) < 20
    ** Patients receiving a 5-alpha reductase inhibitor must have a PSA < 10
    * Grade group 1-3
    * Lymph node negative
    * Negative for distant metastases
inclusion: True
